Stay hungry to be free...
-
Pfizer-BioNTech announce early positive update from German phase 1/2 COVID-19 vaccine study
Biopharmaceutical New Technologies (BioNTech) and Pfizer announced on Monday that they have received early positive results from the German phase one and two trials of their co-developed coronavirus vaccine (BNT162B1). Key takeaways: "New preliminary data from German study support and expand upon recently disclosed early results from corresponding US trial with BNT162B1." "Overall, data suggested that BNT162B1 could potentially be administered safely, with a manageable tolerability profile." Market reaction: This headline seems to be providing a boost to market sentiment. At the moment, the S&P 500 futures are ... (full story)
- Comments
- Subscribe
- Comment #1
- Quote
- Jul 20, 2020 9:09am Jul 20, 2020 9:09am
- denya
- Joined Jun 2011 | Status: Member | 63 Comments
- Comment #2
- Quote
- Jul 20, 2020 9:22am Jul 20, 2020 9:22am
- JustBreathe
- | Joined Dec 2019 | Status: Member | 141 Comments
- Comment #3
- Quote
- Jul 20, 2020 10:05am Jul 20, 2020 10:05am
- Guest
- | IP XX.XXX.121.112
- Comment #4
- Quote
- Jul 20, 2020 2:58pm Jul 20, 2020 2:58pm
- ettrader
- | Joined Aug 2009 | Status: Member | 504 Comments